Charged-particle multiplicity distributions over a wide pseudorapidity range in proton-proton collisions at root s=0.9, 7, and 8 TeV

We present the charged-particle multiplicity distributions over a wide pseudorapidity range ( $-\,3.4<\eta <5.0$ ) for pp collisions at $\sqrt{s}= 0.9, 7$ , and 8 TeV at the LHC. Results are based on information from the Silicon Pixel Detector and the Forward Multiplicity Detector of ALICE, extending the pseudorapidity coverage of the earlier publications and the high-multiplicity reach. The measurements are compared to results from the CMS experiment and to PYTHIA, PHOJET and EPOS LHC event generators, as well as IP-Glasma calculations.We present the charged-particle multiplicity distributions over a wide pseudorapidity range ($-3.4<\eta<5.0$) for pp collisions at $\sqrt{s}=$ 0.9, 7, and 8 TeV at the LHC. Results are based on information from the Silicon Pixel Detector and the Forward Multiplicity Detector of ALICE, extending the pseudorapidity coverage of the earlier publications and the high-multiplicity reach. The measurements are compared to results from the CMS experiment and to PYTHIA, PHOJET and EPOS LHC event generators, as well as IP-Glasma calculations

Charged-particle multiplicity distributions over a wide pseudorapidity range in proton-proton collisions at root s=0.9, 7, and 8 TeV

We present the charged-particle multiplicity distributions over a wide pseudorapidity range ( $-\,3.4<\eta <5.0$ ) for pp collisions at $\sqrt{s}= 0.9, 7$ , and 8 TeV at the LHC. Results are based on information from the Silicon Pixel Detector and the Forward Multiplicity Detector of ALICE, extending the pseudorapidity coverage of the earlier publications and the high-multiplicity reach. The measurements are compared to results from the CMS experiment and to PYTHIA, PHOJET and EPOS LHC event generators, as well as IP-Glasma calculations.We present the charged-particle multiplicity distributions over a wide pseudorapidity range ($-3.4<\eta<5.0$) for pp collisions at $\sqrt{s}=$ 0.9, 7, and 8 TeV at the LHC. Results are based on information from the Silicon Pixel Detector and the Forward Multiplicity Detector of ALICE, extending the pseudorapidity coverage of the earlier publications and the high-multiplicity reach. The measurements are compared to results from the CMS experiment and to PYTHIA, PHOJET and EPOS LHC event generators, as well as IP-Glasma calculations

Factors that affect in passing the nurse licensure examination as perceived by selected nursing graduates of De La Salle - Health Sciences Campus Batch 2005

The study utilized a non-experimental, descriptive type of design. Purposive sampling technique was applied to select the respondents. Out of the 135 nursing graduates of DLSHSC Batch 2005, 128 passed the Nurse Licensure Examination and 50 graduates responded to the call to participate in the study. The data gathering instrument was a checklist type of questionnaire. Data was analyzed through frequency distribution, mean, t-test and ANOVA. The following conclusions were drawn: 1) Majority of the respondents were female and obtained their social support from their family; 2) The selected nursing graduates of DLS-HSC Batch 2005 agreed to moderate extent that review was one of the factors that affect in passing the Nurse Licensure Examination while student factors was agreed to be a factor to a moderate extent; 3) There was no significant difference on the perception of the selected nursing graduates of DLS-HSC Batch 2005 when they were grouped according to gender and social support

Prognostic Value of Dobutamine Stress Echocardiography With Early Injection of Atropine With Versus Without Chronic Beta-Blocker Therapy in Patients With Known or Suspected Coronary Heart Disease

Although a new protocol of dobutamine stress echocardiography with the early injection of atropine (EA-DSE) has been demonstrated to be useful in reducing adverse effects and increasing the number of effective tests and to have similar accuracy for detecting coronary artery disease (CAD) compared with conventional protocols, no data exist regarding its ability to predict long-term events. The aim of this study was to determine the prognostic value of EA-DSE and the effects of the long-term use of beta blockers on it. A retrospective evaluation of 844 patients who underwent EA-DSE for known or suspected CAD was performed; 309 (37%) were receiving beta blockers. During a median follow-up period of 24 months, 102 events (12%) occurred. On univariate analysis, predictors of events were the ejection fraction (p <0.001), male gender (p <0.001), previous myocardial infarction (p <0.001), angiotensin-converting enzyme inhibitor therapy (p = 0.021), calcium channel blocker therapy (p = 0.034), and abnormal results on EA-DSE (p <0.001). On multivariate analysis, the independent predictors of events were male gender (relative risk [RR] 1.78, 95% confidence interval [CI] 1.13 to 2.81, p = 0.013) and abnormal results on EA-DSE (RR 4.45, 95% CI 2.84 to 7.01, p <0.0001). Normal results on EA-DSE with P blockers were associated with a nonsignificant higher incidence of events than normal results on EA-DSE without beta blockers (RR 1.29, 95% CI 0.58 to 2.87, p = 0.54). Abnormal results on EA-DSE with beta blockers had an RR of 4.97 (95% CI 2.79 to 8.87, p <0.001) compared with normal results, while abnormal results on EA-DSE without beta blockers had an RR of 5.96 (95% CI 3.41 to 10.44, p <0.001) for events, with no difference between groups (p = 0.36). In conclusion, the detection of fixed or inducible wall motion abnormalities during EA-DSE was an independent predictor of long-term events in patients with known or suspected CAD. The prognostic value of EA-DSE was not affected by the long-term use of beta blockers. (C) 2008 Elsevier Inc. All rights reserved. (Am J Cardiol 2008;102:1291-1295